Waterloo researchers make a significant step towards reliably processing quantum information
New optical system designed to target and control individual atoms
2023-09-11
(Press-News.org)
Using laser light, researchers have developed the most robust method currently known to control individual qubits made of the chemical element barium. The ability to reliably control a qubit is an important achievement for realizing future functional quantum computers.
This new method, developed at the University of Waterloo’s Institute for Quantum Computing (IQC), uses a small glass waveguide to separate laser beams and focus them four microns apart, about four-hundredths of the width of a single human hair. The precision and extent to which each focused laser beam on its target qubit can be controlled in parallel is unmatched by previous research.
“Our design limits the amount of crosstalk–the amount of light falling on neighbouring ions–to the very small relative intensity of 0.01 per cent, which is among the best in the quantum community,” said Dr. K. Rajibul Islam, a professor at IQC and Waterloo’s Department of Physics and Astronomy. “Unlike previous methods to create agile controls over individual ions, the fibre-based modulators do not affect each other.
“This means we can talk to any ion without affecting its neighbours while also retaining the capability to control each individual ion to the maximum possible extent. This is the most flexible ion qubit control system with this high precision that we know of anywhere, in both academia and industry.”
The researchers targeted barium ions, which are becoming increasingly popular in the field of trapped ion quantum computation. Barium ions have convenient energy states that can be used as the zero and one levels of a qubit and be manipulated with visible green light, unlike the higher energy ultraviolet light needed for other atom types for the same manipulation. This allows the researchers to use commercially available optical technologies that are not available for ultraviolet wavelengths.
The researchers created a waveguide chip that divides a single laser beam into 16 different channels of light. Each channel is then directed into individual optical fibre-based modulators which independently provide agile control over each laser beam’s intensity, frequency, and phase. The laser beams are then focused down to their small spacing using a series of optical lenses similar to a telescope. The researchers confirmed each laser beam’s focus and control by measuring them with precise camera sensors.
“This work is part of our effort at the University of Waterloo to build barium ion quantum processors using atomic systems,” said Dr. Crystal Senko, Islam’s co-principal investigator and a faculty member at IQC and Waterloo’s Department of Physics and Astronomy. “We use ions because they are identical, nature-made qubits, so we don’t need to fabricate them. Our task is to find ways to control them.”
The new waveguide method demonstrates a simple and precise method of control, showing promise for manipulating ions to encode and process quantum data and for implementation in quantum simulation and computing.
The paper, A guided light system for agile individual addressing of Ba+ qubits with 10−4 level intensity crosstalk, was published by Ali Binai-Motlagh, Dr. Matt Day, Nikolay Videnov, Noah Greenberg, Senko and Islam in Quantum Science and Technology.
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2023-09-11
(Singapore – 10:05 a.m. SGT--September 11, 2023) – Osimertinib plus chemotherapy demonstrated a statistically significant and clinically meaningful progression-free survival benefit compared to osimertinib alone, according to research presented today at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer in Singapore.
The FLAURA2 study was led by Dr. Pasi A. Jänne from the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute in Boston, Mass.
Osimertinib, a potent third-generation EGFR-TKI with central nervous system activity, has garnered attention for its targeted ...
2023-09-11
(Singapore, September 11, 2023, 10:05 a.m. SGT) – Extended pleurectomy decortication combined with chemotherapy is associated with worse survival outcomes, a higher incidence of serious adverse events, and a diminished quality of life compared to platinum and pemetrexed chemotherapy alone, according to research presented today the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer in Singapore.
The UK Multicentre Randomised Trial, known as MARS 2, conducted by a team led by Professor Eric ...
2023-09-11
(Singapore – 10:05 a.m. SGT--September 11, 2023) – A modified adenocarcinoma classification approach significantly enhances reproducibility and may be an improvement on the existing World Health Organization classification system, according to research unveiled at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer in Singapore.
The study, led by Dr. Erik Thunnissen, Department of Pathology, Amsterdam UMC, VU Medical Center, Amsterdam, The Netherlands, ...
2023-09-11
First-ever National Screening Program to Consider Family History
(Singapore – 10:05 a.m. SGT--September 11, 2023) – The Taiwan National Lung Cancer Early Detection Program detected 85 percent of lung cancer cases at either a phase 0 or phase 1 level, demonstrating that lung cancer screening can detect lung cancer at an early enough phase to allow doctors to intervene more effectively.
The results of the program were presented by Pan-Chyr Yang, MD, PhD from the National Taiwan University Hospital, at the International Association for the Study of Lung Cancer 2023 World Conference ...
2023-09-11
[Singapore, 10:05 a.m. SGT--September 11, 2023] – Adding perioperative durvalumab to neoadjuvant chemotherapy did not adversely impact surgery in patients with resectable NSCLC and was associated with a tolerable surgical safety profile, according to research presented today from the phase 3 AEGEAN trial at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer in Singapore.
"The AEGEAN trial demonstrated a clinically meaningful improvement in EFS ...
2023-09-11
Milan, Italy: People suffering with obstructive sleep apnoea (OSA) can reduce their risk of dying from cardiovascular disease if they use a continuous positive airway pressure (CPAP) machine at night, according to research presented at the European Respiratory Society International Congress in Milan, Italy [1].
CPAP may also work better than a weight loss drug in reducing the build-up of plaque in the arteries around the heart, according to a pilot study also presented at the European Respiratory Society International Congress [2].
People with OSA often snore loudly, their breathing starts and stops during the night, and they may ...
2023-09-11
Milan, Italy: Young children growing up in towns and cities suffer from more respiratory infections than those who grow up in the countryside, according to research presented at the European Respiratory Society International Congress in Milan, Italy [1].
A second study, presented at the Congress and published in Pediatric Pulmonology today (Monday) [2], shows that factors such as attending day care, living in a damp home or near dense traffic increase the risk of chest infections in young children, while breastfeeding reduces the risk.
Researchers say that some children, who are otherwise healthy, can suffer with repeated infections, so it is important to understand why ...
2023-09-10
Milan, Italy: Babies and young children with more mature communities of bacteria present in their gut are less likely to develop allergy-related wheezing or asthma, according to research presented at the European Respiratory Society International Congress in Milan, Italy [1].
These communities of bacteria, known as microbiota, develop in the human body during the early years of life and are involved in processes that are helpful to the body, such as synthesising vitamins and boosting the immune system, or occasionally unhelpful, such as the role they play ...
2023-09-10
About The Study: Among individuals with uncontrolled hypertension in this randomized clinical trial that included 200 participants, use of lorundrostat was effective at lowering blood pressure compared with placebo, which will require further confirmatory studies.
Authors: Steven E. Nissen, M.D., of the Cleveland Clinic Foundation, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2023.16029)
Editor’s Note: Please see the article for additional ...
2023-09-10
[Singapore -- 10:35 a.m. SGT--September 10, 2023] - The combination of benmelstobart, anlotinib, and chemotherapy demonstrated significant benefits compared to placebo and chemotherapy in terms of median progression-free survival and overall survival for patients with extensive-stage small-cell lung cancer.
The research was presented today at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer in Singapore.
Extensive-stage small-cell lung cancer is a challenging malignancy to treat, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Waterloo researchers make a significant step towards reliably processing quantum information
New optical system designed to target and control individual atoms